静脈疾患治療の世界市場：業界動向と予測（～2030年）

世界の静脈疾患治療の市場規模は、2023年～2030年の予測期間に7.3%のCAGRを記録すると予測されています。

静脈疾患の発生率上昇、静脈疾患治療における技術進歩、高齢者人口の増加などが、世界の静脈疾患治療市場の主要な成長促進要因です。

当レポートでは、世界の静脈疾患治療市場について調査分析し、市場概要、セグメント別・地域別の市場分析、競合分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 市場内訳

第3章 エグゼクティブサマリー

第4章 重要考察

• PESTEL分析
• ポーターのファイブフォース

第5章 世界の静脈疾患治療市場：業界洞察

第6章 疫学

第7章 規制の枠組み

第8章 市場概要

• 促進要因
• 抑制要因
• 機会
• 課題

第9章 世界の静脈疾患治療市場：製品タイプ別

• 概要
• 硬化療法注射
  • 硬化療法：タイプ別
  • 皮下：用途別
• アブレーション装置
  • サーマルアブレーション
  • 非熱的アブレーション
• 静脈クロージャー製品
  • 静脈クロージャー製品：処置別
  • 静脈クロージャー製品：技術別
• 静脈ステント
  • 静脈ステント：技術別
  • 静脈ステント：用途別
• 投薬
• その他

第10章 世界の静脈疾患治療市場：疾患タイプ別

• 概要
• 静脈瘤
• 深部静脈血栓症（DVT）
• 肺塞栓症
• 慢性静脈不全（CVI）
• 表在性血栓性静脈炎
• その他

第11章 世界の静脈疾患治療市場：治療タイプ別

• 概要
• 硬化療法
• 高周波焼灼療法
• レーザー治療
• 外来での静脈摘出術
• 静脈結紮と剥離
• 血管形成術・ステント術
• 外科手術
• 圧迫療法
• 静脈内投与
• 大静脈フィルター
• その他の治療法

第12章 世界の静脈治療疾患市場：エンドユーザー別

• 概要
• 病院
• クリニック
• 外来手術センター
• その他

第13章 世界の静脈疾患治療市場：流通チャネル別

• 概要
• 直接入札
• 小売販売
• その他

第14章 世界の静脈疾患治療市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • ロシア
  • スペイン
  • トルコ
  • オランダ
  • ベルギー
  • スイス
  • アイルランド
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • インドネシア
  • シンガポール
  • マレーシア
  • フィリピン
  • 韓国
  • タイ
  • その他アジア太平洋
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト
  • イスラエル
  • その他中東・アフリカ

第15章 世界の静脈疾患治療市場：企業情勢

• 企業シェア分析：世界
• 企業シェア分析：北米
• 企業シェア分析：欧州
• 企業シェア分析：アジア太平洋

第16章 SWOT分析

第17章 企業プロファイル

• MEDTRONIC
• BOSTON SCIENTIFIC CORPORATION
• VARIAN MEDICAL SYSTEMS, INC.
• STRYKER
• KONINKLIJKE PHILIPS N.V.
• ABBOTT
• ALMA LASERS
• ANGIODYNAMICS
• B.BRAUN MELSUNGEN AG
• BAYLIS MEDICAL COMPANY, INC
• BD
• CANDELA MEDICAL

• 17.13 CARL ZEISS MEDITEC AG 426
  • 17.13.1 COMPANYSNAPSHOT 426
  • 17.13.2 REVENUE ANALYSIS 426
  • 17.13.3 PRODUCT PORTFOLIO 427
  • 17.13.4 RECENT DEVELOPMENT 427
• 17.14 COOK 428
  • 17.14.1 COMPANY SNAPSHOT 428
  • 17.14.2 PRODUCT PORTFOLIO 428
  • 17.14.3 RECENT DEVELOPMENTS 428
• 17.15 IMRICOR 429
  • 17.15.1 COMPANY SNAPSHOT 429
  • 17.15.2 REVENUE ANALYSIS 429
  • 17.15.3 PRODUCT PORTFOLIO 430
  • 17.15.4 RECENT DEVELOPMENT 430
• 17.16 OLYMPUS CORPORATION 431
  • 17.16.1 COMPANY SNAPSHOT 431
  • 17.16.2 REVENUE ANALYSIS 431
  • 17.16.3 PRODUCT PORTFOILIO 432
  • 17.16.4 RECENT DEVELOPMENT 432
• 17.17 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH 433
  • 17.17.1 COMPANY SNAPSHOT 433
  • 17.17.2 PRODUCT PORTFOLIO 433
  • 17.17.3 RECENT DEVELOPMENTS 433
• 17.18 PLUSMEDICA.DE 434
  • 17.18.1 COMPANY SNAPSHOT 434
  • 17.18.2 PRODUCT PORTFOLIO 434
  • 17.18.3 RECENT DEVELOPMENT 434
• 17.19 SCITECH 435
  • 17.19.1 COMPANY SNAPSHOT 435
  • 17.19.2 PRODUCT PORTFOLIO 435
  • 17.19.3 RECENT DEVELOPMENTS 435
• 17.20 SMITH + NEPHEW 436
  • 17.20.1 COMPANY SNAPSHOT 436
  • 17.20.2 REVENUE ANALYSIS 436
  • 17.20.3 PRODUCT PORTFOLIO 437
  • 17.20.4 RECENT DEVELOPMENT 437
• 17.21 SONABLATE 438
  • 17.21.1 COMPANY SNAPSHOT 438
  • 17.21.2 PRODUCT PORTFOLIO 438
  • 17.21.3 RECENT DEVELOPMENT 438
• 17.22 THERACLION 439
  • 17.22.1 COMPANY SNAPSHOT 439
  • 17.22.2 REVENUE ANALYSIS 439
  • 17.22.3 PRODUCT PORTFOLIO 440
  • 17.22.4 RECENT DEVELOPMENT 440
• 17.23 TELEFLEX INCORPORATED 441
  • 17.23.1 COMPANY SNAPSHOT 441
  • 17.23.2 REVENUE ANALYSIS 441
  • 17.23.3 PRODUCT PORTFOLIO 442
  • 17.23.4 RECENT DEVELOPMENTS 442
• 17.24 TERUMO CORPORATION 443
  • 17.24.1 COMPANY SNAPSHOT 443
  • 17.24.2 REVENUE ANALYSIS 443
  • 17.24.3 PRODUCT PORTFOLIO 444
  • 17.24.4 RECENT DEVELOPMENTS 444

18 QUESTIONNAIRE 445

19 RELATED REPORTS 448

LIST OF TABLES

• TABLE 1 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 101
• TABLE 2 GLOBAL SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 102
• TABLE 3 GLOBAL SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 102
• TABLE 4 GLOBAL SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 103
• TABLE 5 GLOBAL ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 104
• TABLE 6 GLOBAL ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
• TABLE 7 GLOBAL THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 105
• TABLE 8 GLOBAL RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 105
• TABLE 9 GLOBAL LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 106
• TABLE 10 GLOBAL ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 106
• TABLE 11 GLOBAL RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 107
• TABLE 12 GLOBAL ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
• TABLE 13 GLOBAL NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
• TABLE 14 GLOBAL CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
• TABLE 15 GLOBAL VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 111
• TABLE 16 GLOBAL VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 111
• TABLE 17 GLOBAL VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 112
• TABLE 18 GLOBAL VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 113
• TABLE 19 GLOBAL VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 113
• TABLE 20 GLOBAL ILIAC VEIN STENT TECHNOLOGY IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 114
• TABLE 21 GLOBAL MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 115
• TABLE 22 GLOBAL OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 115
• TABLE 23 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 119
• TABLE 24 GLOBAL VARICOSE VEINS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 120
• TABLE 25 GLOBAL DEEP VEIN THROMBOSIS (DVT) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 121
• TABLE 26 GLOBAL PULMONARY EMBOLISM IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 121
• TABLE 27 GLOBAL CHRONIC VENOUS INSUFFICIENCY (CVI) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 122
• TABLE 28 GLOBAL SUPERFICIAL THROMBOPHLEBITIS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 123
• TABLE 29 GLOBAL OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 124
• TABLE 30 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 128
• TABLE 31 GLOBAL SCELEROTHERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 129
• TABLE 32 GLOBAL RADIOFREQUENCY ABLATION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 130
• TABLE 33 GLOBAL LASER TREATMENT IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 130
• TABLE 34 GLOBAL AMBULATORY PHELEBECTOMY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 131
• TABLE 35 GLOBAL VEIN LIGATION AND STRIPPING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 132
• TABLE 36 GLOBAL ANGIOPLASTY OR STENTING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 132
• TABLE 37 GLOBAL SURGERIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 133
• TABLE 38 GLOBAL COMPRESSION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 134
• TABLE 39 GLOBAL VEINACTIVE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 135
• TABLE 40 GLOBAL VENA CAVA FILTER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 135
• TABLE 41 GLOBAL OTHER THERAPIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 136
• TABLE 42 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 140
• TABLE 43 GLOBAL HOSPITALS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 141
• TABLE 44 GLOBAL CLINICS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 142
• TABLE 45 GLOBAL AMBULATORY SURGICAL CENTERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 142
• TABLE 46 GLOBAL OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 143
• TABLE 47 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 147
• TABLE 48 GLOBAL DIRECT TENDER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 148
• TABLE 49 GLOBAL RETAIL SALES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 149
• TABLE 50 GLOBAL OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 149
• TABLE 51 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION) 155
• TABLE 52 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 160
• TABLE 53 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
• TABLE 54 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 160
• TABLE 55 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
• TABLE 56 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
• TABLE 57 NORTH AMERICA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
• TABLE 58 NORTH AMERICA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
• TABLE 59 NORTH AMERICA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
• TABLE 60 NORTH AMERICA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
• TABLE 61 NORTH AMERICA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
• TABLE 62 NORTH AMERICA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
• TABLE 63 NORTH AMERICA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
• TABLE 64 NORTH AMERICA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
• TABLE 65 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 163
• TABLE 66 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 163
• TABLE 67 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 164
• TABLE 68 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 164
• TABLE 69 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 164
• TABLE 70 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 165
• TABLE 71 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 165
• TABLE 72 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 165
• TABLE 73 U.S. VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166
• TABLE 74 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 166
• TABLE 75 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
• TABLE 76 U.S. ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
• TABLE 77 U.S. THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
• TABLE 78 U.S. RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
• TABLE 79 U.S. LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
• TABLE 80 U.S. ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
• TABLE 81 U.S. RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
• TABLE 82 U.S. ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
• TABLE 83 U.S. NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
• TABLE 84 U.S. CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
• TABLE 85 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 169
• TABLE 86 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 169
• TABLE 87 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 170
• TABLE 88 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 170
• TABLE 89 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 170
• TABLE 90 U.S. VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 171
• TABLE 91 U.S. VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 171
• TABLE 92 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 171
• TABLE 93 CANADA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
• TABLE 94 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
• TABLE 95 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
• TABLE 96 CANADA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
• TABLE 97 CANADA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
• TABLE 98 CANADA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
• TABLE 99 CANADA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
• TABLE 100 CANADA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
• TABLE 101 CANADA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
• TABLE 102 CANADA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
• TABLE 103 CANADA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
• TABLE 104 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 175
• TABLE 105 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 175
• TABLE 106 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 176
• TABLE 107 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 176
• TABLE 108 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 176
• TABLE 109 CANADA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 177
• TABLE 110 CANADA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 177
• TABLE 111 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 177
• TABLE 112 MEXICO VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178
• TABLE 113 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 178
• TABLE 114 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
• TABLE 115 MEXICO ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
• TABLE 116 MEXICO THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
• TABLE 117 MEXICO RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
• TABLE 118 MEXICO LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
• TABLE 119 MEXICO ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
• TABLE 120 MEXICO RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
• TABLE 121 MEXICO ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
• TABLE 122 MEXICO NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
• TABLE 123 MEXICO CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
• TABLE 124 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 181
• TABLE 125 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 181
• TABLE 126 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 182
• TABLE 127 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 182
• TABLE 128 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 182
• TABLE 129 MEXICO VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 183
• TABLE 130 MEXICO VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 183
• TABLE 131 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 183
• TABLE 132 EUROPE VENOUS DISEASES TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 188
• TABLE 133 EUROPE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
• TABLE 134 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
• TABLE 135 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 189
• TABLE 136 EUROPE ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
• TABLE 137 EUROPE THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
• TABLE 138 EUROPE RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
• TABLE 139 EUROPE LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
• TABLE 140 EUROPE ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
• TABLE 141 EUROPE RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
• TABLE 142 EUROPE ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
• TABLE 143 EUROPE NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
• TABLE 144 EUROPE CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
• TABLE 145 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION) 192
• TABLE 146 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 192
• TABLE 147 EUROPE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 192
• TABLE 148 EUROPE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 192
• TABLE 149 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION) 193
• TABLE 150 EUROPE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION) 193
• TABLE 151 EUROPE VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION) 193
• TABLE 152 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 194
• TABLE 153 GERMANY VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 195
• TABLE 154 GERMANY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION) 195
• TABLE 155 GERMANY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 195
• TABLE 156 GERMANY ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
• TABLE 157 GERMANY THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
• TABLE 158 GERMANY RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
• TABLE 159 GERMANY LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196

LIST OF FIGURES

• FIGURE 1 GLOBAL VENOUS DISEASES TREATMENT MARKET: SEGMENTATION 60
• FIGURE 2 GLOBAL VENOUS DISEASES TREATMENT MARKET: DATA TRIANGULATION 63
• FIGURE 3 GLOBAL VENOUS DISEASES TREATMENT MARKET: DROC ANALYSIS 64
• FIGURE 4 GLOBAL VENOUS DISEASES TREATMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 65
• FIGURE 5 GLOBAL VENOUS DISEASES TREATMENT MARKET: COMPANY RESEARCH ANALYSIS 65
• FIGURE 6 GLOBAL VENOUS DISEASES TREATMENT MARKET: INTERVIEW DEMOGRAPHICS 66
• FIGURE 7 GLOBAL VENOUS DISEASES TREATMENT MARKET: MARKET END USER COVERAGE GRID 68
• FIGURE 8 GLOBAL VENOUS DISEASES TREATMENT MARKET: DBMR MARKET POSITION GRID 70
• FIGURE 9 GLOBAL VENOUS DISEASES TREATMENT MARKET: VENDOR SHARE ANALYSIS 72
• FIGURE 10 GLOBAL VENOUS DISEASES TREATMENT MARKET: SEGMENTATION 76
• FIGURE 11 GROWING AWARENESS ABOUT VENOUS DISEASES TREATMENTS AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL VENOUS DISEASES TREATMENT MARKET FROM 2023 TO 2030 77
• FIGURE 12 THE ABLATION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VENOUS DISEASES TREATMENT MARKET IN 2023 & 2030 77
• FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL VENOUS DISEASES TREATMENT MARKET, AND ASIA PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 78
• FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL VENOUS DISEASES TREATMENTS MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030 79
• FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE GLOBAL VENOUS DISEASES TREATMENT MARKET 89
• FIGURE 16 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2022 99
• FIGURE 17 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION) 100
• FIGURE 18 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, CAGR (2023-2030) 100
• FIGURE 19 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, LIFELINE CURVE 101
• FIGURE 20 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2022 117
• FIGURE 21 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2023-2030 (USD MILLION) 118
• FIGURE 22 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, CAGR (2023-2030) 118
• FIGURE 23 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, LIFELINE CURVE 119
• FIGURE 24 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2022 126
• FIGURE 25 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION) 127
• FIGURE 26 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2023-2030) 127
• FIGURE 27 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE 128
• FIGURE 28 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY END USER, 2022 138
• FIGURE 29 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY END USER, 2023-2030 (USD MILLION) 139
• FIGURE 30 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY END USER, CAGR (2023-2030) 139
• FIGURE 31 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY END USER, LIFELINE CURVE 140
• FIGURE 32 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2022 145
• FIGURE 33 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 146
• FIGURE 34 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 146
• FIGURE 35 GLOBAL VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 147
• FIGURE 36 GLOBAL VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 152
• FIGURE 37 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY REGION (2022) 153
• FIGURE 38 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY REGION (2023 & 2030) 153
• FIGURE 39 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY REGION (2022 & 2030) 154
• FIGURE 40 GLOBAL VENOUS DISEASES TREATMENT MARKET: BY PRODUCT TYPE (2023 & 2030) 154
• FIGURE 41 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 157
• FIGURE 42 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 158
• FIGURE 43 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 158
• FIGURE 44 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 159
• FIGURE 45 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 159
• FIGURE 46 EUROPE VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 185
• FIGURE 47 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 186
• FIGURE 48 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 186
• FIGURE 49 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 187
• FIGURE 50 EUROPE VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 187
• FIGURE 51 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 263
• FIGURE 52 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 264
• FIGURE 53 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 264
• FIGURE 54 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 265
• FIGURE 55 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 265
• FIGURE 56 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 334
• FIGURE 57 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 335
• FIGURE 58 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 335
• FIGURE 59 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 336
• FIGURE 60 SOUTH AMERICA VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 336
• FIGURE 61 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022) 358
• FIGURE 62 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022) 359
• FIGURE 63 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030) 359
• FIGURE 64 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030) 360
• FIGURE 65 MIDDLE EAST AND AFRICA VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030) 360
• FIGURE 66 GLOBAL VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%) 399
• FIGURE 67 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%) 400
• FIGURE 68 EUROPE VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%) 401
• FIGURE 69 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%) 402

The global venous diseases treatment market is projected to register a CAGR of 7.3% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Global Venous Diseases Treatment Market, By Product Type (Ablation Devices, Venous Stents, Venous Closure Products, Sclerotherapy Injection and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins and Others), Treatment Type (Surgeries, Scelrotherapy, Angioplasty Or Stenting, Vein Legation and Stripping, Vena Cava Filter, Ambulatory Phlebectomy, Radiofrequency Ablation Therapy, Laser Treatment and Other Therapies) End User (Hospitals, Clinics, Ambulatory Surgical Centers and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, France, Russia, Italy, U.K., Spain, Turkey, Netherlands, Belgium, Switzerland, Ireland, Rest of Europe, China, India, Japan, Indonesia, Philippines, Thailand, Australia, Malaysia, South Korea, Singapore, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America) Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of the venous diseases treatment market are:

Rising incidence of venous diseases

Technological advancement in the treatment of venous diseases

Increase in the geriatric population

Market Players:

The key market players for the global venous diseases treatment market are listed below:

Abbott

Alma Lasers

Angiodynamics

B.Braun Melsungen AG

Baylis Medical Company, Inc

BD

Boston Scientific Corporation

Candela Medical

Carl Zeiss Meditec AG

Cook

Imricor

Koninklijke Philips N.V.

Medtronic

Olympus Corporation

Optimed Medizinische Instrumente GmbH

Plusmedica.de

SCITECH

Smith + Nephew

Sonablate

Stryker

Teleflex Incorporated

Terumo Corporation

Theraclion

Varian Medical Systems, Inc.

TABLE OF CONTENTS

1 INTRODUCTION 52

• 1.1 OBJECTIVES OF THE STUDY 52
• 1.2 MARKET DEFINITION 52
• 1.3 OVERVIEW OF THE GLOBAL VENOUS DISEASES TREATMENT MARKET 52
• 1.4 CURRENCY AND PRICING 54
• 1.5 LIMITATIONS 55
• 1.6 MARKETS COVERED 55

2 MARKET SEGMENTATION 60

• 2.1 MARKETS COVERED 60
• 2.2 GEOGRAPHICAL SCOPE 61
• 2.3 YEARS CONSIDERED FOR THE STUDY 62
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 63
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
• 2.6 MULTIVARIATE MODELLING 67
• 2.7 MARKET END USER COVERAGE GRID 68
• 2.8 INSTRUMENT BASED LIFELINE CURVE 69
• 2.9 DBMR MARKET POSITION GRID 70
• 2.10 VENDOR SHARE ANALYSIS 72
• 2.11 SECONDARY SOURCES 73
• 2.12 ASSUMPTIONS 73

3 EXECUTIVE SUMMARY 74

4 PREMIUM INSIGHTS 77

• 4.1 PESTEL ANALYSIS 80
• 4.2 PORTER'S FIVE FORCES 81

5 GLOBAL VENOUS DISEASES TREATMENT MARKET, INDUSTRY INSIGHTS 82

6 EPIDEMIOLOGY 84

7 REGULATORY FRAMEWORK 85

8 MARKET OVERVIEW 88

• 8.1 DRIVERS 90
  • 8.1.1 RISING INCIDENCES OF VENOUS DISEASES 90
  • 8.1.2 RAPID CHANGES IN LIFESTYLE LEAD TO OBESITY RESULTING IN VENOUS DISEASES 90
  • 8.1.3 INCREASE IN THE GERIATRIC POPULATION 91
  • 8.1.4 TECHNOLOGICALLY ADVANCEMENT IN THE TREATMENT OF VENOUS DISEASES 92
• 8.2 RESTRAINTS 93
  • 8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 93
  • 8.2.2 INADEQUATE REIMBURSEMENT COVERAGE 93
• 8.3 OPPORTUNITIES 94
  • 8.3.1 RISING AWARENESS TOWARDS VENOUS DISORDERS 94
  • 8.3.2 NEED FOR PROPER DIAGNOSIS AND TREATMENT OF VENOUS DISEASES 94
  • 8.3.3 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES 95
  • 8.3.4 OCCUPATIONAL LIFESTYLE INCREASES THE NEED FOR VENOUS DISEASE TREATMENT 95
• 8.4 CHALLENGES 96
  • 8.4.1 HIGH COST ASSOCIATED WITH VENOUS DISEASE TREATMENT 96
  • 8.4.2 SIDE EFFECTS AND RISK ASSOCIATED WITH DIFFERENT TREATMENT MODES 97

9 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE 98

• 9.1 OVERVIEW 99
• 9.2 SCLEROTHERAPY INJECTION 102
  • 9.2.1 SCLEROTHERAPY, BY TYPE 102
    • 9.2.1.1 INTRAVENOUS 103
    • 9.2.1.2 INTRADERMAL 103
    • 9.2.1.3 SUBCUTANEOUS 103
  • 9.2.2 SUBCUTANEOUS, BY APPLICATION 103
    • 9.2.2.1 MALFORMED LYMPHED VESSELS 103
    • 9.2.2.2 HEMORRHOIDS 103
    • 9.2.2.3 HYDROCELES 103
    • 9.2.2.4 OTHERS 103
• 9.3 ABLATION DEVICES 103
  • 9.3.1 THERMAL ABLATION 104
    • 9.3.1.1 RADIOFREQUENCY 105
      • 9.3.1.1.1 CATHETER MANIPULATION SYSTEMS 105
      • 9.3.1.1.2 TEMPERATURE CONTROLLED 105
      • 9.3.1.1.3 FLUID COOLED 106
    • 9.3.1.2 LIGHT 106
      • 9.3.1.2.1 EXCIMER LASERS 106
      • 9.3.1.2.2 COLD LASERS 106
    • 9.3.1.3 ULTRASOUND 106
      • 9.3.1.3.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) 107
      • 9.3.1.3.2 SHOCK WAVE LITHOTRIPSY 107
      • 9.3.1.3.3 MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND (MRI-FUS) 107
      • 9.3.1.3.4 ULTRASONIC SURGICAL SYSTEMS 107
    • 9.3.1.4 RADIATION 107
      • 9.3.1.4.1 STEREOTACTIC BODY RADIATION THERAPY 108
      • 9.3.1.4.2 INTENSITY-MODULATED RADIATION THERAPY 108
      • 9.3.1.4.3 STEREOTACTIC RADIOTHERAPY & RADIOSURGERY 108
      • 9.3.1.4.4 IMAGE GUIDED RADIATION THERAPY 108
      • 9.3.1.4.5 INTRAVASCULAR BRACHYTHERAPY 108
      • 9.3.1.4.6 PROTON BEAM THERAPY 108
    • 9.3.1.5 ELECTRICAL 108
      • 9.3.1.5.1 ELECTRICAL ABLATORS 109
      • 9.3.1.5.2 ELECTRONIC BRACHYTHERAPY 109
    • 9.3.1.6 MICROWAVE 109
    • 9.3.1.7 HYDROTHERMAL 109
  • 9.3.2 NON-THERMAL ABLATION 109
    • 9.3.2.1 CRYOABLATION 109
      • 9.3.2.1.1 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES 110
      • 9.3.2.1.2 CRYOGEN SPRAY PROBE 110
      • 9.3.2.1.3 TISSUE CONTACT PROBE 110
    • 9.3.2.2 HYDROMECHANICAL ABLATION 110
• 9.4 VENOUS CLOSURE PRODUCTS 110
  • 9.4.1 VENOUS CLOSURE PRODUCTS, BY PROCEDURE 111
    • 9.4.1.1 INTERVENTIONAL CARDIOLOGY 111
    • 9.4.1.2 INTERVENTIONAL RADIOLOGY 111
  • 9.4.2 VENOUS CLOSURE PRODUCTS, BY TECHNOLOGY 111
    • 9.4.2.1 FEMORAL ACCESS TECHNIQUE 112
    • 9.4.2.2 RADIAL ACCESS TECHNIQUE 112
• 9.5 VENOUS STENTS 112
  • 9.5.1 VENOUS STENTS, BY TECHNOLOGY 113
    • 9.5.1.1 WALLSTENT TECHNOLOGY 113
    • 9.5.1.2 ILIAC VEIN STENT TECHNOLOGY 113
  • 9.5.2 VENOUS STENTS, BY APPLICATION 113
    • 9.5.2.1 LEG 114
    • 9.5.2.2 CHEST 114
    • 9.5.2.3 ABDOMEN 114
    • 9.5.2.4 OTHERS 114
• 9.6 MEDICATION 114
• 9.7 OTHERS 115

10 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE 116

• 10.1 OVERVIEW 117
• 10.2 VARICOSE VEINS 120
• 10.3 DEEP VEIN THROMBOSIS (DVT) 120
• 10.4 PULMONARY EMBOLISM 121
• 10.5 CHRONIC VENOUS INSUFFICIENCY (CVI) 122
• 10.6 SUPERFICIAL THROMBOPHLEBITIS 122
• 10.7 OTHERS 123

11 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE 125

• 11.1 OVERVIEW 126
• 11.2 SCLEROTHERAPY 129
• 11.3 RADIOFREQUENCY ABLATION THERAPY 129
• 11.4 LASER TREATMENT 130
• 11.5 AMBULATORY PHLEBECTOMY 131
• 11.6 VEIN LIGATION AND STRIPPING 131
• 11.7 ANGIOPLASTY OR STENTING 132
• 11.8 SURGERIES 133
• 11.9 COMPRESSION THERAPY 133
• 11.10 VEINACTIVE MEDICATION 134
• 11.11 VENA CAVA FILTER 135
• 11.12 OTHER THERAPIES 136

12 GLOBAL VENOUS TREATMENT DISEASES MARKET, BY END USER 137

• 12.1 OVERVIEW 138
• 12.2 HOSPITALS 141
• 12.3 CLINICS 141
• 12.4 AMBULATORY SURGICAL CENTERS 142
• 12.5 OTHERS 143

13 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL 144

• 13.1 OVERVIEW 145
• 13.2 DIRECT TENDER 148
• 13.3 RETAIL SALES 148
• 13.4 OTHERS 149

14 GLOBAL VENOUS DISEASES TREATMENT MARKET, BY REGION 150

• 14.1 OVERVIEW 151
• 14.2 NORTH AMERICA 156
  • 14.2.1 U.S. 166
  • 14.2.2 CANADA 172
  • 14.2.3 MEXICO 178
• 14.3 EUROPE 184
  • 14.3.1 GERMANY 195
  • 14.3.2 U.K. 201
  • 14.3.3 FRANCE 207
  • 14.3.4 ITALY 213
  • 14.3.5 RUSSIA 219
  • 14.3.6 SPAIN 225
  • 14.3.7 TURKEY 231
  • 14.3.8 NETHERLANDS 237
  • 14.3.9 BELGIUM 243
  • 14.3.10 SWITZERLAND 249
  • 14.3.11 IRELAND 255
  • 14.3.12 REST OF EUROPE 261
• 14.4 ASIA-PACIFIC 262
  • 14.4.1 CHINA 272
  • 14.4.2 JAPAN 278
  • 14.4.3 INDIA 284
  • 14.4.4 AUSTRALIA 290
  • 14.4.5 INDONESIA 296
  • 14.4.6 SINGAPORE 302
  • 14.4.7 MALAYSIA 308
  • 14.4.8 PHILIPPINES 314
  • 14.4.9 SOUTH KOREA 320
  • 14.4.10 THAILAND 326
  • 14.4.11 REST OF ASIA-PACIFIC 332
• 14.5 SOUTH AMERICA 333
  • 14.5.1 BRAZIL 344
  • 14.5.2 ARGENTINA 350
  • 14.5.3 REST OF SOUTH AMERICA 356
• 14.6 MIDDLE EAST & AFRICA 357
  • 14.6.1 SOUTH AFRICA 368
  • 14.6.2 SAUDI ARABIA 374
  • 14.6.3 U.A.E. 380
  • 14.6.4 EGYPT 386
  • 14.6.5 ISRAEL 392
  • 14.6.6 REST OF MIDDLE EAST AND AFRICA 398

15 GLOBAL VENOUS DISEASES TREATMENT MARKET, COMPANY LANDSCAPE 399

• 15.1 COMPANY SHARE ANALYSIS: GLOBAL 399
• 15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 400
• 15.3 COMPANY SHARE ANALYSIS: EUROPE 401
• 15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 402

16 SWOT ANALYSIS 403

17 COMPANY PROFILE 404

• 17.1 MEDTRONIC 404
  • 17.1.1 COMPANY SNAPSHOT 404
  • 17.1.2 REVENUE ANALYSIS 404
  • 17.1.3 COMPANY SHARE ANALYSIS 405
  • 17.1.4 PRODUCT PORTFOLIO 405
  • 17.1.5 RECENT DEVELOPMENTS 405
• 17.2 BOSTON SCIENTIFIC CORPORATION 406
  • 17.2.1 COMPANY SNAPSHOT 406
  • 17.2.2 REVENUE ANALYSIS 406
  • 17.2.3 COMPANY SHARE ANALYSIS 407
  • 17.2.4 PRODUCT PORTFOLIO 407
  • 17.2.5 RECENT DEVELOPMENTS 408
• 17.3 VARIAN MEDICAL SYSTEMS, INC. 409
  • 17.3.1 COMPANY SNAPSHOT 409
  • 17.3.2 COMPANY SHARE ANALYSIS 409
  • 17.3.3 PRODUCT PORTFOLIO 410
  • 17.3.4 RECENT DEVELOPMENT 410
• 17.4 STRYKER 411
  • 17.4.1 COMPANY SNAPSHOT 411
  • 17.4.2 REVENUE ANALYSIS 411
  • 17.4.3 COMPANY SHARE ANALYSIS 412
  • 17.4.4 PRODUCT PORTFOLIO 412
  • 17.4.5 RECENT DEVELOPMENT 412
• 17.5 KONINKLIJKE PHILIPS N.V. 413
  • 17.5.1 COMPANY SNAPSHOT 413
  • 17.5.2 REVENUE ANALYSIS 413
  • 17.5.3 COMPANY SHARE ANALYSIS 414
  • 17.5.4 PRODUCT PORTFOLIO 414
  • 17.5.5 RECENT DEVELOPMENT 414
• 17.6 ABBOTT 415
  • 17.6.1 COMPANY SNAPSHOT 415
  • 17.6.2 REVENUE ANALYSIS 415
  • 17.6.3 PRODUCT PORTFOLIO 416
  • 17.6.4 RECENT DEVELOPMENT 416
• 17.7 ALMA LASERS 417
  • 17.7.1 COMPANY SNAPSHOT 417
  • 17.7.2 PRODUCT PORTFOLIO 417
  • 17.7.3 RECENT DEVELOPMENT 417
• 17.8 ANGIODYNAMICS 418
  • 17.8.1 COMPANY SNAPSHOT 418
  • 17.8.2 REVENUE ANALYSIS 418
  • 17.8.3 PRODUCT PORTFOLIO 419
  • 17.8.4 RECENT DEVELOPMENT 419
• 17.9 B.BRAUN MELSUNGEN AG 420
  • 17.9.1 COMPANY SNAPSHOT 420
  • 17.9.2 REVENUE ANALYSIS 420
  • 17.9.3 PRODUCT PORTFOLIO 421
  • 17.9.4 RECENT DEVELOPMENTS 421
• 17.10 BAYLIS MEDICAL COMPANY, INC 422
  • 17.10.1 COMPANY SNAPSHOT 422
  • 17.10.2 PRODUCT PORTFOLIO 422
  • 17.10.3 RECENT DEVELOPMENT 422
• 17.11 BD 423
  • 17.11.1 COMPANY SNAPSHOT 423
  • 17.11.2 REVENUE ANALYSIS 423
  • 17.11.3 PRODUCT PORTFOLIO 424
  • 17.11.4 RECENT DEVELOPMENT 424
• 17.12 CANDELA MEDICAL 425
  • 17.12.1 COMPANY SNAPSHOT 425
  • 17.12.2 PRODUCT PORTFOLIO 425
  • 17.12.3 RECENT DEVELOPMENT 425